We also performed immunohistochemistry on tumour sections for MET and phosphoMET which showed expression in control, ETV1 and ERG tumours with a statistically representative increase in ETV1 tumours and slight increase in ERG tumours, as shown in Fig. 5 for MET and Fig. S8 for phosphoMET. The gene discussed is ETV1; the disease is neoplasm.